Analyst I BioAnalytical

Job Location
Indianapolis, IN
Job Description

Covance is currently seeking an Analyst 1 for the BioAnalytical Department at the Indianapolis, IN site.

As an Analyst 1 you will:
- Learn to conduct routine analyses in compliance with applicable methods, protocols, SOPs, and regulatory agency guidelines.
- Learn how to document work and maintain study documentation and laboratory records.
- Learn how to use laboratory equipment appropriate for assigned tasks.
- Attend and participates in project meetings.
- Learn to perform QC review of data.
- Learn to recognize deviations from normal results and informs Study Director, Principal Investigator and/or management of any problems and/or deviations that may affect the integrity of the data.
- Learn to plan assigned workload on a daily basis and effectively schedule multiple assignments.
- Contribute to a cohesive team environment.
- Plan individual workload in coordination with team members.
- Support process improvement initiatives.
- Maintain a clean and safe laboratory work environment.
- Perform other related duties as assigned.
- Learn to interact with internal clients.

- Bachelor of Science/Arts (BS/BA) degree in chemistry or related scientific field.
- Experience may be substituted for education.
- Familiar with the use of standard laboratory equipment.
- Basic knowledge of computers and software programs.
Experience Required:
- No experience required.
EEO Employer Covance is committed to diversity in the workplace and is an equal opportunity employer (Minority/Female/Individual with Disability/Veteran). Your confidentiality and privacy are important to us.

About Our Organization

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.